Japan Gaming Market Report 2020 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Games Country Report - Japan" report has been added to ResearchAndMarkets.com's offering.…
5 years ago
India Gaming Report 2020-2024 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Games Country Report - India" report has been added to ResearchAndMarkets.com's offering.…
5 years ago
Global and Chinese Diamond Mining Industry (2021 to 2026) – Key Trends and Developments – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Diamond Mining Industry, 2021 Market Research Report" report has been…
5 years ago
Kraken Expands Crypto Access to GBP and AUD Markets with Greatest Addition of New Trading Pairs to Date
Kraken has significantly ramped up the number of direct trading pairs available to GBP and…
5 years ago
AM Best Affirms Credit Ratings of Fidelity Life Assurance Company Limited
SINGAPORE--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term…
5 years ago
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of ‘EuCorVac-19’ in Korea
- Starting the Phase I/II trial in Eunpyeong St. Mary’s Hospital SEOUL, South Korea--(BUSINESS WIRE)--#AntibodyResponse--EuBiologics…
5 years ago
China Dynamics Welcomes New International Investors
Shareholding Reflects Industry Confidence in Global Electric Bus Market HONG KONG SAR - Media OutReach -…
5 years ago
RapidAI Enhancing Stroke Care Across Australia
SAN MATEO, Calif.--(BUSINESS WIRE)--#Australia--RapidAI, the leader in advanced imaging for stroke, today announced it now…
5 years ago
Rare Element Resources Named U.S. Department of Energy Funding Recipient for Rare Earth Separation and Processing Demonstration Project
DoE selects General Atomics and Rare Element consortium for $21.9 million in funding to advance…
5 years ago
Bio-Thera Solutions Announces Initiation of Phase I Clinical Trial for BAT1308, a Monoclonal Antibody Targeting PD-1
GUANGZHOU, China--(BUSINESS WIRE)--#PD1--Bio-Thera Solutions, Ltd. (SHA: 688177), a commercial-stage pharmaceutical company, today announced that dosing…
5 years ago